OXIGEN LINDE 100% (v/v) Rumænien - rumænsk - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

oxigen linde 100% (v/v)

linde gaz romania s.r.l. - romania - oxigenum - gaz medicinal, comprimat - 100%(v/v) - alte preparate terapeutice gaze medicinale

TRI-OTIC OINTMENT Australien - engelsk - APVMA (Australian Pesticides and Veterinary Medicines Authority)

tri-otic ointment

bioniche - gentamicin as sulfate(3000iu/g)+clotrimazole(10mg/g) + others - topical cream, ointment, paste, gel, lotion - antibiotic,antifungal - dog | bitch | castrate | puppy - anti-infective or antiseptic | malassezia pachydermatis | otitis externa | acute canine otitis | associated with yeast &/or bac | bacterial infections | chronic canine otitis | conjunctivitis | eye infections | eye-washes | keratoconjunctivitis | malassezia pachydermatis | ocular infections | otitis (canine) | pityrosporum pachydermatis | seborrhoeic dermatitis

Krystexxa Den Europæiske Union - dansk - EMA (European Medicines Agency)

krystexxa

crealta pharmaceuticals ireland limited - pegloticase - gigt - antigout præparater - krystexxa er indiceret til behandling af svær invaliderende kroniske tophaceous gigt i voksne patienter der kan have erosive fælles engagement og der har ikke kunnet normalisere serum urinsyre med xanthin oxidase hæmmere på maksimalt lægeligt passende dosis eller for hvem disse lægemidler er kontraindiceret.

Lamivudine Teva Pharma B.V. Den Europæiske Union - dansk - EMA (European Medicines Agency)

lamivudine teva pharma b.v.

teva b.v.  - lamivudin - hiv infektioner - antivirale midler til systemisk anvendelse - lamivudin teva pharma b. indikeres som en del af antiretroviral kombinationsbehandling til behandling af humane immunsvigt-virus (hiv) -inficerede voksne og børn.

Estraderm MX Australien - engelsk - Department of Health (Therapeutic Goods Administration)

estraderm mx

novartis pharmaceuticals australia pty ltd - oestradiol; oestradiol hemihydrate -

ESTRADERM MX 25 estradiol 25 microgram/24 hours transdermal drug delivery system sachet Australien - engelsk - Department of Health (Therapeutic Goods Administration)

estraderm mx 25 estradiol 25 microgram/24 hours transdermal drug delivery system sachet

juno pharmaceuticals pty ltd - estradiol hemihydrate, quantity: 0.77 mg (equivalent: estradiol, qty 0.75 mg) - drug delivery system, transdermal - excipient ingredients: isopropyl palmitate; polyethylene terephthalate; ethyl acetate; acrylic acid; 2-ethylhexyl acrylate; methyl acrylate; glycidyl methacrylate; 2,2'-azobisisobutyronitrile; hexane - menopausal symptoms: short-term treatment of signs and symptoms of oestrogen deficiency due to menopause, whether natural or surgically induced. in women with an intact uterus, oestrogen should always be opposed by progestogen in an adequate dosage regimen to ensure secretory transformation of the endometrium at regular intervals (refer to section 5.1 pharmacodynamic properties - clinical trials and section 4.2 dose and method of administration). estraderm mx 25 is not indicated for the prevention of post-menopausal bone mineral density loss. combination hrt should not be used in hysterectomised women because it is not needed in these women and it may increase risk of breast cancer